Carlsmed (CARL) executive compensation, 2026 proxy

Mike Cordonnier, Chief Executive Officer, President and Co-Founder, was paid $2.8M in 2025, up 436% from $520,693 the year before.

Filed
April 22, 2026
Annual meeting
June 3, 2026
Pay year
2025
Named executives
3
CEO total pay
$2.8M+436% vs prior year
CEO pay in equity
67%$1.9M in awards
CEO Target Bonus
75%Percentage of annual base salary
CFO Target Bonus
50%Percentage of annual base salary
CCO Target Bonus
60%Percentage of annual base salary
Bonus Payout Percentage
115%Achievement level determined by Board

How Cordonnier was paid

$2.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary17%Stock awards13%Option awards54%Non-equity incentive15%All other compensation1%

Named executive officers

ExecutiveTotal
Mike CordonnierChief Executive Officer, President and Co-Founder$2,789,967
Leo GreensteinChief Financial Officer and Treasurer$1,119,311
Scott DurallChief Commercial Officer$1,516,272

What changed and why

  • $2.8MMike Cordonnier received total compensation of $2,789,967 for fiscal year 2025.
  • Base salaries for all named executive officers increased effective July 22, 2025, in connection with the IPO.
  • 115%Annual cash incentive awards were paid out at 115% of target levels based on performance metrics.
  • Option awards comprised the largest portion of the CEO total compensation for 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.